Selected article for: "immune response and MERS cov"

Author: Shitao Rao; Alexandria Lau; Hon-Cheong So
Title: Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of 2019-nCov: A Mendelian Randomization analysis
  • Document date: 2020_3_8
  • ID: myh73pe6_46
    Snippet: Similarly, DM was also common in patients infected with MERS-CoV 36,37 . Kulcsar et al. built a mouse model susceptible to MERS-CoV infection and induced type 2 DM using a high-fat diet. They found that, if affected by the virus, these diabetic mice suffered from a prolonged phase of disease and delayed recovery, which might be due to a dysregulated immune response 38 . With regards to comorbidity with cancers, Liang et al. recently carried out a.....
    Document: Similarly, DM was also common in patients infected with MERS-CoV 36,37 . Kulcsar et al. built a mouse model susceptible to MERS-CoV infection and induced type 2 DM using a high-fat diet. They found that, if affected by the virus, these diabetic mice suffered from a prolonged phase of disease and delayed recovery, which might be due to a dysregulated immune response 38 . With regards to comorbidity with cancers, Liang et al. recently carried out a nationwide analysis of 1,590 patients with laboratory-confirmed COVID-19 and suggested that cancer patients might have a higher infection risk than those without 39 . The study also reported higher risk of severe complications in such patients.

    Search related documents:
    Co phrase search for related documents
    • cancer patient and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cancer patient and infection risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
    • cancer patient and MERS cov: 1, 2, 3, 4
    • cancer patient and MERS cov infection: 1, 2
    • cancer patient and mouse model: 1, 2, 3, 4, 5
    • cancer patient and severe complication: 1, 2
    • cancer patient and virus affect: 1
    • delay recovery and high risk: 1, 2, 3
    • delay recovery and infection risk: 1
    • diabetic mouse and high fat: 1
    • diabetic mouse and high fat diet: 1
    • diabetic mouse and induced type: 1
    • diabetic mouse and mouse model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • disease prolonged phase and high fat: 1
    • disease prolonged phase and high fat diet: 1
    • disease prolonged phase and immune response: 1
    • disease prolonged phase and induced type: 1
    • disease prolonged phase and MERS cov: 1
    • disease prolonged phase and MERS cov infection: 1